Skip to main content

Los Angeles Primary Care

Formerly in the Silver Lake neighborhood of Los Angeles, now welcoming patients at our new home in Glendale, CA.

Formerly in the Silver Lake neighborhood of Los Angeles, now welcoming patients at our new home in Glendale, CA.

Women's Health · Menopause Care · Glendale, CA

Perimenopausal HRT Options:
Comparing Your Choices

If you haven't had a hysterectomy and you're weighing hormone therapy for perimenopause, here's how three common approaches compare — including contraception, safety considerations, and what to expect day to day.

No Hysterectomy Combined Oral Contraceptive Estradiol Patch + Progesterone Estradiol Patch + Slynd
Glendale Burbank La Cañada Flintridge La Crescenta Hollywood
Transdermal · Gel · Ring · Oral · SprayEstrogen delivery options
Oral · IUDProgesterone delivery options
IndividualizedCare based on your history

Where to Start

There's no single
right answer

Perimenopause brings a mix of needs — symptom relief, bone protection, and often still a need for contraception, since pregnancy remains possible until you've fully reached menopause. If you still have your uterus, any estrogen therapy has to be balanced with adequate progesterone to protect the uterine lining.

Sera Ramadan, D.O. at Los Angeles Primary Care in Glendale, CA works with patients throughout Glendale, Burbank, La Cañada Flintridge, La Crescenta, and Hollywood to weigh these options against personal history — migraine history, blood pressure, clotting risk, and what matters most to you day to day.


Understanding the Research

What about the Women's Health Initiative?

If you've heard hormone therapy is dangerous, you're likely thinking of the 2002 Women's Health Initiative (WHI) study, which reported higher rates of breast cancer and cardiovascular events in women on HRT. That finding caused hormone therapy use to drop by as much as 80% almost overnight, and the fear it created has lingered for over two decades.

Since then, extensive reanalysis has shown that the original findings don't tell the whole story. The WHI studied a synthetic, oral estrogen-progestin combination in women whose average age was 63 — many of them a decade or more past menopause, not the recently perimenopausal population this page is written for. Later follow-up data showed that women who start hormone therapy within about 10 years of menopause see a different picture: reduced all-cause mortality, reduced cardiovascular disease, and no increased breast cancer risk with estrogen alone. This is often called the "timing hypothesis," and it's now widely accepted in the medical community.

In short: the WHI wasn't wrong, but its results were misapplied. It said less about hormone therapy in general and more about one specific formulation, taken by an older population, at a later stage of life. That distinction matters for the choices on this page.


Side by Side

Three approaches
if you still have your uterus

Each option balances contraception, symptom relief, and safety differently. Here's how they compare.

Option 1

Combined Oral Contraceptive (COC)

Benefits

  • Provides contraception — still important in perimenopause, since pregnancy remains possible
  • Controls menstrual irregularities and heavy bleeding effectively
  • Alleviates vasomotor symptoms, mood changes, and other perimenopausal symptoms
  • Preserves bone density
  • Suppresses ovarian function, reducing the hormonal fluctuations that drive symptoms

Drawbacks

  • Higher estrogen dose than menopausal HRT, with greater blood clot and stroke risk, especially after age 40
  • Not recommended for women with migraine with aura, uncontrolled hypertension, smoking after 35, or a history of blood clots
  • More impact on the liver — clotting factors and triglycerides — than bioidentical estradiol
  • Can mask the menopausal transition, making it harder to know when menopause has occurred
  • Natural estrogen-containing formulations may be preferred after age 40 to reduce cardiovascular risk

Option 2

Estradiol Patch + Oral Micronized Progesterone

Benefits

  • Transdermal estradiol bypasses first-pass liver metabolism, for a lower blood clot risk and neutral effect on triglycerides
  • Micronized progesterone is associated with lower breast cancer risk than synthetic progestins
  • Favorable lipid and mood profile compared to synthetic progestins
  • Flexible, low-starting-dose patch options

Drawbacks

  • Does not provide contraception on its own
  • Patch adhesion issues or skin irritation in some patients
  • Progesterone can cause drowsiness, bloating, or mood changes
Cyclic dosing Taken on a schedule for 12–14 days each month, this provides reliable endometrial protection and a predictable withdrawal bleed, which some women prefer — with less total progesterone exposure.
Continuous nightly dosing Taken every night, this eliminates monthly bleeding over time and offers the most effective endometrial protection, though with somewhat higher total progesterone exposure.

Option 3

Estradiol Patch + Slynd (Drospirenone)

Benefits

  • Same transdermal estradiol advantages as Option 2 — lower clot risk, liver-neutral
  • Anti-mineralocorticoid effect may lower blood pressure and reduce bloating and water retention
  • Anti-androgenic effects — can help with acne and unwanted hair growth
  • Provides contraception, since Slynd is an FDA-approved progestin-only pill
  • Favorable effect on total cholesterol and LDL
  • May improve blood vessel function and arterial stiffness

Drawbacks

  • Less long-term safety data on breast cancer risk compared to micronized progesterone
  • Risk of elevated potassium — not appropriate with certain blood pressure medications or kidney disease; potassium monitoring is recommended
  • This specific combination is used off-label and has less dedicated research on endometrial safety
  • More expensive than generic micronized progesterone
  • May cause breakthrough bleeding, especially at first

Also Worth Knowing

More ways to
personalize your treatment

The three options above aren't the only building blocks. How you take your estrogen, and how you protect your uterine lining, can each be adjusted independently:

Progesterone Delivery

Oral vs. IUD

Progesterone protects your uterine lining, and there's more than one way to deliver it:

  • Oral micronized progesterone — taken by mouth on a cyclic or nightly schedule, with effects felt throughout the body
  • Progesterone-releasing IUD (such as Mirena) — delivers progestin locally to the uterus rather than systemically, often meaning lighter or absent periods, plus it doubles as highly effective contraception
Estrogen Delivery

Estrogen Comes in More Than One Form

A patch isn't the only way to take estrogen. Depending on your preferences and how your body responds, estrogen can also be delivered as a:

  • Transdermal patch — worn on the skin and changed on a regular schedule
  • Gel — applied daily to the skin
  • Ring — worn internally and replaced periodically
  • Oral tablet — taken by mouth
  • Spray — applied daily to the skin

Every one of these — the progestogen you pair it with and the way you take your estrogen — can be personalized based on your goals, your health history, and how your body tolerates treatment. Finding the right fit is often a process of adjusting together over time, not a single decision made at one visit.


At a Glance

Summary comparison

FeatureCOCPatch + Micronized ProgesteronePatch + Slynd
ContraceptionYesNoYes (Slynd is progestin-only)
Blood clot riskHigher (oral estrogen)Lower (transdermal)Lower (transdermal)
Breast cancer riskEstrogen-dose dependentLikely lowest with cyclic dosingLess data; synthetic progestin
Blood pressure effectNeutral / slight increaseNeutralMay lower BP
Bleeding patternPredictable withdrawalCyclic: withdrawal · Continuous: none24/4 cycle; some breakthrough
Anti-androgenic benefitDepends on formulationNoYes
Endometrial safety evidenceExtensiveWell-establishedLimited for this combination
Good to know: hormone therapy decisions depend heavily on your individual health history, including migraine patterns, blood pressure, clotting risk, and family history. This page is a general overview — Sera Ramadan, D.O. reviews your full picture with you before recommending a specific option.

Common Questions

Questions patients ask
about perimenopausal HRT

Three common approaches are a combined oral contraceptive, an estradiol patch paired with oral micronized progesterone, and an estradiol patch paired with Slynd. Each balances contraception, symptom control, and safety differently — we'll help you choose based on your personal history.
An estradiol patch combined with micronized progesterone does not provide contraception. An estradiol patch combined with Slynd does, since Slynd is an FDA-approved progestin-only pill.
Transdermal estradiol bypasses first-pass liver metabolism, which is generally associated with a lower risk of blood clots than oral estrogen. The right choice still depends on individual factors like age, migraine history, blood pressure, and whether you need contraception.
Cyclic dosing produces a predictable monthly bleed and involves less total progesterone exposure. Continuous dosing eliminates monthly bleeding and offers slightly stronger endometrial protection. We'll walk through the trade-offs with you.
Yes. Oral micronized progesterone and a progesterone-releasing IUD, such as Mirena, are both ways to protect the uterine lining while you use estrogen therapy — oral progesterone works throughout the body, while the IUD delivers progestin locally. The IUD also provides highly effective contraception, which can be appealing if you'd rather not take a daily pill or manage a monthly bleed.
A transdermal patch is one option, but estrogen also comes as a gel, a ring, an oral tablet, or a spray. Each has a slightly different absorption profile, and we'll help you find the form that fits your routine and how your body responds.
That's a reference to the 2002 Women's Health Initiative study, which studied an older, synthetic oral formulation in women with an average age of 63. Later reanalysis found that women who start hormone therapy within about 10 years of menopause — the population this page is written for — have a different, more favorable risk profile, including no increased breast cancer risk with estrogen alone.
Yes. Sera Ramadan, D.O. sees patients from Glendale, Burbank, La Cañada Flintridge, La Crescenta, Hollywood, and across greater Los Angeles for perimenopausal and menopausal hormone therapy care.

Ready to find the option
that fits you?

Sera Ramadan, D.O. will review your health history and help you choose the perimenopausal HRT approach that fits your needs — serving Glendale, Burbank, La Cañada Flintridge, La Crescenta, and Hollywood.

Book an Appointment